Resolution of Erosive Esophagitis After Conversion from Vertical Sleeve Gastrectomy to Roux-en-Y Gastric Bypass.
Endoscopy
Erosive esophagitis
GERD
Revisional
Roux-e-Y gastric bypass
Sleeve gastrectomy
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
27
04
2020
accepted:
10
08
2020
revised:
03
08
2020
pubmed:
18
8
2020
medline:
15
4
2021
entrez:
18
8
2020
Statut:
ppublish
Résumé
Laparoscopic sleeve gastrectomy (LSG) has become the preferred bariatric procedure in many countries. However, there is one shortcoming of LSG in the long-term follow-up, and this is the onset of gastro-esophageal reflux disease (GERD) and erosive esophagitis (EE). Conversion to Roux-en-Y gastric bypass (RYGB) is considered an option in patients unresponsive to medical therapy. Currently, there is no evidence of EE improvement or resolution after conversion surgery. In this study, we objectively evaluate the effectiveness of RYGB in management of EE with upper endoscopy (EGD) to identify the significant variables in patients with GERD symptoms post LSG refractory to medical therapy and require conversion surgery. Over a period of 11 years (2008-2019) at Singapore General Hospital, we retrospectively reviewed a prospectively collected database of a cohort of patients whom had conversion surgery to RYGB for refractory GERD and EE after LSG. Patient's endoscopic findings and demographic and anthropometric data were analyzed. We identified a total of 14 patients who underwent LSG to RYGB conversions for endoscopic proven erosive esophagitis in our unit during the study period. Eight patients (57.1%) had concurrent hiatal hernia repaired. Nine (64.3%) patients were females. The median age of patients in this cohort was 44 (range 30-61) years. Mean weight and BMI were 87.7 kg (± 19.2) and 32.8 (± 3.09) kg/m2, respectively, on the day of conversion surgery. The median time between LSG and revision to RYGB was 36 (range 6-68) months. Seven patients (50%) had complete resolution of GERD symptoms after conversion, and 6 patients (42.9%) had partial resolution. Six out of 7 patients had complete resolution of EE. There were 4 anastomotic strictures (28.6%). Older patients, Indian ethnicity, present of hiatal hernia and lower weight loss after initial LSG were more likely to undergo conversion surgery. Conversion to RYGB after LSG is clinically relevant and may be a feasible solution if patients have ongoing GERD refractory to medical therapy. Ninety-three percent of our patients achieved complete resolution of their GERD symptoms and significant improvement of erosive esophagitis with significant weight loss after conversion. This study has important implications as LSG is increasingly being performed and a proportion of these will need revision surgery for various reasons, particularly GERD which is extremely prevalent.
Sections du résumé
BACKGROUND
BACKGROUND
Laparoscopic sleeve gastrectomy (LSG) has become the preferred bariatric procedure in many countries. However, there is one shortcoming of LSG in the long-term follow-up, and this is the onset of gastro-esophageal reflux disease (GERD) and erosive esophagitis (EE). Conversion to Roux-en-Y gastric bypass (RYGB) is considered an option in patients unresponsive to medical therapy. Currently, there is no evidence of EE improvement or resolution after conversion surgery. In this study, we objectively evaluate the effectiveness of RYGB in management of EE with upper endoscopy (EGD) to identify the significant variables in patients with GERD symptoms post LSG refractory to medical therapy and require conversion surgery.
METHODS
METHODS
Over a period of 11 years (2008-2019) at Singapore General Hospital, we retrospectively reviewed a prospectively collected database of a cohort of patients whom had conversion surgery to RYGB for refractory GERD and EE after LSG. Patient's endoscopic findings and demographic and anthropometric data were analyzed.
RESULTS
RESULTS
We identified a total of 14 patients who underwent LSG to RYGB conversions for endoscopic proven erosive esophagitis in our unit during the study period. Eight patients (57.1%) had concurrent hiatal hernia repaired. Nine (64.3%) patients were females. The median age of patients in this cohort was 44 (range 30-61) years. Mean weight and BMI were 87.7 kg (± 19.2) and 32.8 (± 3.09) kg/m2, respectively, on the day of conversion surgery. The median time between LSG and revision to RYGB was 36 (range 6-68) months. Seven patients (50%) had complete resolution of GERD symptoms after conversion, and 6 patients (42.9%) had partial resolution. Six out of 7 patients had complete resolution of EE. There were 4 anastomotic strictures (28.6%). Older patients, Indian ethnicity, present of hiatal hernia and lower weight loss after initial LSG were more likely to undergo conversion surgery.
CONCLUSION
CONCLUSIONS
Conversion to RYGB after LSG is clinically relevant and may be a feasible solution if patients have ongoing GERD refractory to medical therapy. Ninety-three percent of our patients achieved complete resolution of their GERD symptoms and significant improvement of erosive esophagitis with significant weight loss after conversion. This study has important implications as LSG is increasingly being performed and a proportion of these will need revision surgery for various reasons, particularly GERD which is extremely prevalent.
Identifiants
pubmed: 32803710
doi: 10.1007/s11695-020-04913-6
pii: 10.1007/s11695-020-04913-6
pmc: PMC7429122
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4751-4759Commentaires et corrections
Type : CommentIn
Références
WHO Media Centre: obesity and overweight. Available at: http://www.who.int/mediacentre/factsheets/fs311/en/index.html . 2014. Accessed March, 2017.
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Washington, DC: U.S. DHHS, Public Health Service (PHS); 1998.
Allison DB, Fontaine KR, Manson JE, et al. VanItallie TB annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530–8.
doi: 10.1001/jama.282.16.1530
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.
doi: 10.1056/NEJMoa1200225
Angrisani L, Santonicola A, Iovino P, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28:3783–94.
doi: 10.1007/s11695-018-3450-2
Lim CH, Lee PC, Lim E, et al. Correlation between symptomatic gastro-esophageal reflux disease (GERD) and erosive esophagitis (EE) post vertical sleeve gastrectomy (VSG). Obes Surg. 2019;29:207–14.
doi: 10.1007/s11695-018-3509-0
Cheung D, Switzer NJ, Gill RS, et al. Revisional bariatric surgery following failed primary laparoscopic sleeve gastrectomy: a systematic review. Obes Surg. 2014;24(10):1757–63.
doi: 10.1007/s11695-014-1332-9
Hendricks L, Alvarenga E, Dhanabalsamy N, et al. Impact of sleeve gastrectomy on gastresophageal reflux disease in a morbidly obese population undergoing bariatric surgery. Surg Obes Relat Dis. 2016;12(3):511–7.
doi: 10.1016/j.soard.2015.08.507
Abdemur A, Fendrich I, Rosenthal R. Laparoscopic conversion of laparoscopic sleeve gastrectomy to gastric bypass for intractable gastresophageal reflux disease. Surg Obes Relat Dis. 2012;8(5):654.
doi: 10.1016/j.soard.2011.06.004
Gautier T, Sarcher T, Contival N, et al. Indications and mid-term results of conversion from sleeve gastrectomy to roux-en-Y gastric bypass. Obes Surg. 2013;23(2):212–5.
doi: 10.1007/s11695-012-0782-1
Langer FB, Bohdjalian A, Shakeri-Leidenmühler S, et al. Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass- indications and outcome. Obes Surg. 2010;20(7):835–40.
doi: 10.1007/s11695-010-0125-z
van Rutte PW, Smulders JF, de Zoete JP, et al. Indications and short term outcomes of revisional surgery after failed or complicated sleeve gastrectomy. Obes Surg. 2012;22(12):1903–8.
doi: 10.1007/s11695-012-0774-1
Amiki M, Seki Y, Kasama K, et al. Revisional bariatric surgery for insufficient weight loss and gastroesophageal reflux disease: our 12-year experience. Obes Surg. 2020;30:1671–8.
doi: 10.1007/s11695-019-04374-6
Gagner M, Deitel M, Kalberer TL, et al. The second international consensus summit for sleeve gastrectomy. Surg Obes Relat Dis. 2009;5(4):476–85.
doi: 10.1016/j.soard.2009.06.001
DuPree CE, Kelly B, Steele SR, et al. Laparoscopic sleeve gastrectomy in patients with pre-existing GERD- a National Analysis. JAMA Surg. 2014;149(4):328–34.
doi: 10.1001/jamasurg.2013.4323
Carmeli I, Golomb I, Sadot E, et al. Laparoscopic conversion of sleeve gastrectomy to a biliopancreatic diversion with duodenal switch or a roux en Y gastric bypass due to weight loss failure: our algorithm. Surg Obes Relat Dis. 2015;11(1):79–85.
doi: 10.1016/j.soard.2014.04.012
Homan J, Betzel B, Aarts EO, et al. Secondary surgery after sleeve gastrectomy: Roux-en-Y gastric bypass or biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2015;11(4):771–7.
doi: 10.1016/j.soard.2014.09.029
Zhang L, Tan WH, Chang R, et al. Perioperative risk and complications of revisional bariatric surgery compared to primary Roux-en-Y gastric bypass. Surg Endosc. 2015;29:1316–20.
doi: 10.1007/s00464-014-3848-4
Hallowell PT, Stellato TA, Yao DA, et al. Should bariatric revisional surgery be avoided secondary to increased morbidity and mortality? Am J Surg. 2009;197:391–6.
doi: 10.1016/j.amjsurg.2008.11.011
Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252(2):319–24.
doi: 10.1097/SLA.0b013e3181e90b31
Yorke E, Sheppard C, Switzer NJ, et al. Revision of sleeve gastrectomy to roux-en-Y gastric bypass: a Canadian experience. Am J Surg. 2017;213:970–4.
doi: 10.1016/j.amjsurg.2017.04.003
Parmar CD, Mahawar KK, Boyle M, et al. Conversion of sleeve gastrectomy to roux-en-Y gastric bypass is effective for gastro-oesophageal reflux disease but not for further weight loss. Obes Surg. 2017;27:1651–8.
doi: 10.1007/s11695-017-2542-8
Wang HY, Leene KB, Plymoth A, et al. Prevalence of gastro-esophageal reflux disease and its risk factors in a community based population in southern India. BMC Gastroenterol. 2016;16:36.
doi: 10.1186/s12876-016-0452-1
Lee GL, Tay HW, Ho KY. Curry induces acid reflux and symptoms in gastroesophageal reflux disease. Dig Dis Sci. 2011;56(12):3546–50.
doi: 10.1007/s10620-011-1799-3
Althuwaini S, Bamehriz F, Aldohayan A, et al. Prevalence and predictors of gastroesophageal reflux disease after laparoscopic sleeve gastrectomy. Obes Surg. 2018;28:916–22.
doi: 10.1007/s11695-017-2971-4
Iannelli A, Debs T, Martini F, et al. Laparoscopic conversion of sleeve gastrectomy to roux-en-Y gastric bypass: indications and preliminary results. Surg Obes Relat Dis. 2016;12:1533–8.
doi: 10.1016/j.soard.2016.04.008